Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
- Make smarter investment decisions with TipRanks' Smart Investor Picks, delivered to your inbox every week.
Sirnaomics Ltd. ( (HK:2257) ) has shared an announcement.
Sirnaomics Ltd. has amended the terms of reference for its Nomination Committee, initially adopted in December 2021. The committee, which plays a crucial role in the governance of the company, is composed of at least three directors, with a majority being independent non-executive directors and at least one member of a different gender. This amendment underscores the company’s commitment to diversity and effective governance, potentially enhancing its industry positioning and stakeholder confidence.
More about Sirnaomics Ltd.
Sirnaomics Ltd. operates in the biotechnology industry, focusing on the development of RNAi therapeutics. The company is known for its innovative approaches in creating treatments for various diseases, leveraging RNA interference technology.
Average Trading Volume: 185,497
Technical Sentiment Signal: Hold
Current Market Cap: HK$400.7M
For a thorough assessment of 2257 stock, go to TipRanks’ Stock Analysis page.